Search for: "Jim Greenwood"
Results 1 - 20
of 136
Sorted by Relevance
|
Sort by Date
22 Jan 2016, 3:00 am
The post Jim Greenwood to Chair BIO Ventures for Global Health Board of Directors appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
2 May 2010, 10:30 pm
It was a treat to chat with Jim Greenwood. [read post]
18 Sep 2007, 1:23 pm
Jim Greenwood, CEO of the Biotechnology Industry Organization (BIO), spent some quality time this afternoon answering questions from bloggers about follow-on biologics, patent reform, and FDARA/PDUFA legislation. [read post]
22 Jan 2016, 3:00 am
The post Jim Greenwood to Chair BIO Ventures for Global Health Board of Directors appeared first on... [read post]
5 Sep 2015, 8:28 am
A press release from BusinessWire presented the opinion of BIO's Jim Greenwoodon the recent activities of Kyle Bass:The following statement may be attributed to BIO President and CEO Jim Greenwood: “Billionaire hedge fund manager Kyle Bass continues to attack biotechnology companies with endless series of Inter Parte Review (IPR) challenges to legitimate patents. [read post]
14 Feb 2008, 8:56 pm
By Donald Zuhn -- Earlier today, Patent Docs participated in a conference call with Jim Greenwood (at right), the President and CEO of the Biotechnology Industry Organization (BIO). [read post]
18 Sep 2007, 9:01 pm
By Donald Zuhn -- Earlier today, Patent Docs participated in a conference call with Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO). [read post]
14 Feb 2008, 9:31 am
Noonan -- Earlier today, Patent Docs participated in a conference call with Jim Greenwood (at right), the President and CEO of the Biotechnology Industry Organization (BIO). [read post]
22 Jan 2009, 9:43 pm
By Donald Zuhn -- In an interview with TechJournal South, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood discussed the state of the biotech industry and the biotech issues the new Administration will be facing in the coming year (see "BIO President Sees Biotech Industry Challenges for New Administration"). [read post]
4 Sep 2008, 4:57 am
Noonan -- Earlier today, Patent Docs participated in a conference call with Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO) and Joshua Boger, Ph.D., Chairman of BIO's Board and President and CEO of Vertex Pharmaceuticals Inc. [read post]
16 Aug 2009, 9:59 pm
By Donald Zuhn -- Last week, CNBC anchor Joe Kernen challenged Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood over the wisdom of implementing a follow-on biologics (FOB) regulatory pathway that provides innovator biologics manufacturers with 12 years of exclusivity. [read post]
8 Jul 2009, 9:55 pm
By Donald Zuhn -- During a Wednesday afternoon teleconference, Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO), discussed a recent "flurry of activity" surrounding follow-on biologics legislation currently being debated in Congress. [read post]
26 Aug 2008, 5:00 am
Jim Greenwood lives in a suburb of Dallas, Texas called Frisco. [read post]
16 Feb 2008, 2:54 pm
The Biotechnology Industry Organization CEO, Jim Greenwood, spoke with reporters and bloggers Thursday morning about follow-on biologics and patent reform. [read post]
12 Dec 2014, 7:00 am
From the Desk of Jim Eccleston at Eccleston Law Offices: Paul Greenwood and Stephen Walsh, former executives at WG Trading Co., were sentenced to 10 years in prison for participating in a fraud valued at roughly $554 million that lasted more than a decade. [read post]
8 May 2007, 11:30 am
., Biotechnology Industry Organization (BIO) president and CEO Jim Greenwood commented on the decision, as well as on the amicus brief the organization had previously filed on behalf of Respondent, Teleflex,... [read post]
10 Apr 2008, 9:50 pm
By Donald Zuhn -- On April 1st, we reported on a statement issued by Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood (at right) disputing a report from the Coalition for Patent Fairness that the Senate patent reform bill (S. 1145) would be coming to a vote in the... [read post]
6 Dec 2015, 9:59 pm
By Donald Zuhn -- In an article published earlier this fall on Medium, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood urges Congress to modify the inter partes review (IPR) system, which he argues has "turn[ed] the serious business of medical innovation and entrepreneurial risk-taking into a casino. [read post]
28 Jul 2009, 9:55 pm
By Donald Zuhn -- BIO CEO Cites Letters from Patient Groups Supporting Longer Exclusivity Period Last week, BIO President and CEO Jim Greenwood (at right) noted that a number of patient groups had joined BIO in seeking passage of a follow-on biologics bill providing a minimum of 12 years of data exclusivity. [read post]
2 Dec 2009, 6:57 pm
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) is asking those in the biotech industry to support their work and connect you with others across the industry by joining the IAmBiotech community today. [read post]
